Expert Interview
A second look: Gaining perspective into the limitations on patient access to drugs such as Xanax and Adderall after recent opioid settlements
Ticker(s): IBBInstitution: Cox Health
- Clinical pharmacy specialist in emergency medicine and pain management.
- Spent 8 years in a sickle cell clinic in an urban core hospital.
- Served as a consultant to various medical education groups since 2010. These medical consultations are third party and not affiliated with any pharma corporation.
- Familiar with Oxbryta(voxelotor) and able to discuss the pharmacological profile and use of this drug
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
